Authors
Sr. Principal, Patient Analytics and AI, Team Lead, Global Commercial Solutions, IQVIA
Senior Vice President, Commercial, Stealth Biotech PBC
Vice president and general manager, product management, at IQVIA, where he leads the development of the Commercial Analytics, Agentic, & GenAI Solutions business globally. With over 20 years of experience in technology, data, and analytics, Nasir has held various leadership roles, including senior director and general manager, senior director of machine learning, and director offering lead.
Author of Executive Presence: Step Into Your Power, Convey Confidence, & Lead With Conviction. He has coached more than 2,500 leaders, including pharma and biotech executives.
Strategic Advisor, Rocket Pharmaceuticals
Troy joined Rapport in 2023 with more than two decades of financial leadership experience in the biotech and pharmaceuticals sectors. Over the course of his career, Troy has raised more than $4 billion in capital for life science companies, leading to 8 FDA approved products. Most recently, he was Chief Financial Officer at Karuna Therapeutics, prior to its sale to BMS, where he led the team in the execution of a private crossover round, the company’s IPO and multiple follow-on financings. Prior to Karuna, Troy served as Chief Financial Officer at two other companies, Juventas Therapeutics and scPharmaceuticals. He has a long track record of experience in the sector, having started out at Eli Lilly and then moving on to roles of increasing responsibility at companies including Esperion Therapeutics and the former Insys Therapeutics. Previously, Troy served on the board of CinCor Pharma, Inc., where he advised on the company’s sale to AstraZeneca in early 2023, and currently serves on the boards of Abivax (ABVX), Contineum Therapeutics (CNTM) and Harmony Biosciences (HRMY). Troy is also an advisor to Sofinnova Investments and Patients Capital Management.
Senior Manager, Simon-Kucher, Warsaw
Health Services Sector Leader, PwC
Senior Fellow with the Tufts Center for the Study of Drug Development (CSDD)
Senior director of product management for IQVIA’s Global Commercial Analytics team. With over 15 years of experience, Pahare has been instrumental in building enterprise-grade data, analytics, and AI platforms for global healthcare organizations. He has previously spearheaded product teams to design and launch real-world evidence platforms and CRM solutions tailored for the life sciences industry. His strong foundation in computer science and management, combined with deep expertise in healthcare and life sciences, enables him to create innovative, consumer-grade solutions that drive measurable impact for customers.
Sr. Principal, Patient Analytics and AI, Global Commercial Solutions, IQVIA. With over 20 years of research experience, including 17 years at IQVIA, Göksu has extensive expertise in designing innovative approaches to analyze complex market dynamics using patient-level analytics. Her recent work focuses on building predictive models to facilitate earlier diagnosis and treatment of patients, as well as implementing AI-driven solutions for clinical decision support, web-based screening, and point-of-care tools. She has a strong therapeutic focus on autoimmune disorders, neuroscience, rare diseases, and cardiovascular and respiratory diseases.
Prior to joining IQVIA, Göksu worked at Eli Lilly, where she designed primary market research studies and conducted survey data analysis.
Sissi Pham, PharmD, is the CEO of AESARA Inc.
Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. She has extremely wide experience of international pharmaceutical industry issues, consulting to the world’s leading pharmaceutical companies on global issues. She has been Vice President, European Thought Leadership at IQVIA for 13 years. Sarah presents to hundreds of pharmaceutical industry clients every year on a range of global pharmaceutical industry issues and publishes white papers on many topics including the uptake and impact of innovative medicines and challenges for Launch Excellence. Sarah holds a degree in biochemistry from Oxford University.
Director, Product Offering and Strategy, at IQVIA